Innoviva, Inc. Common Stock
A$31.7
AUD
Last updated on --.
24h volume901.78K
24h highest32.0726 AUD
24h lowest31.2202 AUD
24h Price movement+1.00%
INVA recent prices
24 Hours
+1.00%+A$0.31444
30 days
-2.83%-A$0.92235
60 days
-0.99%-A$0.31444
90 days
-3.57%-A$1.174
Key data
Previous close31.3879 AUD
Market cap2.29B AUD
Volume901.78K
P/E ratio3.250000
Dividend yield (TTM)0.00%
Dividend amount0.34938 AUD
Next ex-dividend dateSep 8, 2015
Next payment dateSep 30, 2015
EPS diluted (TTM)9.5449 AUD
Net income (FY)704.82M AUD
Revenue (FY)587.91M AUD
Last report dateMay 6, 2026
About Innoviva, Inc. Common Stock
HeadquartersBURLINGAME
Employees (FY)159.00
Revenue per employee (FY)3.70M AUD
Net income per employee (FY)4.43M AUD
Listed onNasdaq
INVA conversion tables
 |  |
|---|---|
| 0.5 INVA | 15.85 AUD |
| 1 INVA | 31.7 AUD |
| 5 INVA | 158.51 AUD |
| 10 INVA | 317.02 AUD |
| |
|---|---|
| 0.5 AUD | 0.015772 INVA |
| 1 AUD | 0.031543 INVA |
| 5 AUD | 0.15772 INVA |
| 10 AUD | 0.31543 INVA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
INVA is trading at A$31.70, +1.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The INVA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. INVA is currently trading at A$31.70, +1.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on INVA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. INVA's P/E ratio is currently 3.250000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from INVA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against INVA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Innoviva, Inc. Common Stock's market cap is currently 2.29B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume901.78K
24h highest32.0726 AUD
24h lowest31.2202 AUD
24h Price movement+1.00%
Start trade with INVA Perpetual
Sign up to trade